{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.7643.2.1063","meta":{"versionId":"5","lastUpdated":"2019-01-08T01:00:08.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Oncology Nursing Society Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2019-01-08"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.7643.2.1063","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.7643.2.1063"}],"version":"20190108","name":"AntidiarrhealMedication","title":"Antidiarrheal Medication","status":"active","experimental":false,"date":"2019-01-08T01:00:08-05:00","publisher":"Oncology Nursing Society Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This value set captures concepts related to generic drugs for diphenoxylate hydrochloride and loperamide hydrochloride.),(Data Element Scope: This value set would use the Medication QDM category.),(Inclusion Criteria: This value set contains human, prescribable generic drugs for diphenoxylate hydrochloride and loperamide hydrochloride given orally.),(Exclusion Criteria: Brand name drugs and those not prescribable for humans have been excluded from this value set.)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"1190568","display":"Atropine Sulfate 0.005 MG/ML / Diphenoxylate Hydrochloride 0.5 MG/ML Oral Solution"},{"code":"1190572","display":"Atropine Sulfate 0.025 MG / Diphenoxylate Hydrochloride 2.5 MG Oral Tablet"},{"code":"1250685","display":"Loperamide Hydrochloride 0.133 MG/ML Oral Suspension"},{"code":"2047587","display":"Loperamide Hydrochloride 0.133 MG/ML Oral Solution"},{"code":"977986","display":"Loperamide Hydrochloride 0.2 MG/ML Oral Solution"},{"code":"977998","display":"Loperamide Hydrochloride 2 MG / Simethicone 125 MG Chewable Tablet"},{"code":"978001","display":"Loperamide Hydrochloride 2 MG / Simethicone 125 MG Oral Tablet"},{"code":"978003","display":"Loperamide Hydrochloride 2 MG Chewable Tablet"},{"code":"978006","display":"Loperamide Hydrochloride 2 MG Oral Capsule"},{"code":"978010","display":"Loperamide Hydrochloride 2 MG Oral Tablet"}]}]},"expansion":{"identifier":"urn:uuid:630802a0-160d-4034-833b-d3ee6d996680","timestamp":"2023-12-11T03:19:02-05:00","total":8,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1190568","display":"atropine sulfate 0.005 MG/ML / diphenoxylate hydrochloride 0.5 MG/ML Oral Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1190572","display":"atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1250685","display":"loperamide hydrochloride 0.133 MG/ML Oral Suspension"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"977986","display":"loperamide hydrochloride 0.2 MG/ML Oral Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"977998","display":"loperamide hydrochloride 2 MG / simethicone 125 MG Chewable Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"978001","display":"loperamide hydrochloride 2 MG / simethicone 125 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"978006","display":"loperamide hydrochloride 2 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"978010","display":"loperamide hydrochloride 2 MG Oral Tablet"}]}}